Loading...
Ventas, Inc.
VTR•NYSE
Real EstateREIT - Healthcare Facilities
$63.62
$0.32(0.51%)
Ventas, Inc. (VTR) Financial Performance & Statements
Review Ventas, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
9.48%
↑ 9.48%
Operating Income Growth
2.42%
↑ 2.42%
Net Income Growth
298.06%
↑ 298.06%
Operating Cash Flow Growth
18.73%
↑ 18.73%
Operating Margin
15.10%
↑ 15.10%
Gross Margin
36.67%
↑ 36.67%
Net Profit Margin
2.80%
↑ 2.80%
ROE
1.37%
↑ 1.37%
ROIC
3.13%
↑ 3.13%
Ventas, Inc. (VTR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Ventas, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.29B | $1.24B | $1.20B | $1.20B |
| Cost of Revenue | $741.06M | $714.96M | $976.75M | $989.50M |
| Gross Profit | $546.00M | $521.35M | $224.23M | $210.41M |
| Gross Profit Ratio | $0.42 | $0.42 | $0.19 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.43M | $35.09M | $37.73M | $48.74M |
| Operating Expenses | $350.21M | $521.35M | $377.53M | $63.05M |
| Total Costs & Expenses | $1.09B | $1.04B | $1.02B | $1.05B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $153.21M | $150.44M | $149.26M | $149.93M |
| Depreciation & Amortization | $316.57M | $286.97M | $294.95M | $294.86M |
| EBITDA | $482.96M | $482.38M | $473.37M | $447.62M |
| EBITDA Ratio | $0.38 | $0.39 | $0.39 | $0.37 |
| Operating Income | $195.79M | $195.41M | $178.42M | $147.36M |
| Operating Income Ratio | $0.15 | $0.16 | $0.15 | $0.12 |
| Other Income/Expenses (Net) | -$182.61M | -$171.42M | -$446.08M | -$162.90M |
| Income Before Tax | $13.19M | $24.00M | $28.93M | -$15.54M |
| Income Before Tax Ratio | $0.01 | $0.02 | $0.02 | -$0.01 |
| Income Tax Expense | -$45.54M | $3.002M | $7.77M | -$3.004M |
| Net Income | $56.84M | $19.24M | $19.39M | -$14.31M |
| Net Income Ratio | $0.04 | $0.02 | $0.02 | -$0.01 |
| EPS | $0.13 | $0.05 | $0.05 | -$0.04 |
| Diluted EPS | $0.13 | $0.05 | $0.05 | -$0.04 |
| Weighted Avg Shares Outstanding | $421.50M | $414.60M | $408.10M | $403.37M |
| Weighted Avg Shares Outstanding (Diluted) | $427.61M | $419.47M | $411.82M | $407.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan